Epithalon Peptide Helps Human Cells Overcome the Hayflick Division Limit

The tetrapeptide Epithalon (AEDG) enabled human pulmonary fibroblasts to exceed the Hayflick limit of cell divisions, extending replicative lifespan through telomerase activation — demonstrating anti-aging at the cellular replication level.

Khavinson, V Kh et al.·Bulletin of experimental biology and medicine·2004·Preliminary Evidencein-vitro
RPEP-00933In VitroPreliminary Evidence2004RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in-vitro
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Epithalon peptide treatment enabled human somatic cells to overcome the Hayflick division limit (normally ~50 divisions), extending replicative lifespan through telomerase activation and telomere maintenance.

Key Numbers

How They Did This

in-vitro study examining anti-aging and peptide-design.

Why This Research Matters

Advances understanding of anti-aging, peptide-design, immune-function.

The Bigger Picture

Contributes to peptide research with clinical implications.

What This Study Doesn't Tell Us

Study-specific limitations; see abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation potential to evaluate.

Trust & Context

Key Stat:
Key finding Epithalon peptide treatment enabled human somatic cells to overcome the Hayflick division limit (normally ~50 divisions), extending replicative lifesp
Evidence Grade:
preliminary evidence from in-vitro study.
Study Age:
Published in 2004.
Original Title:
Peptide promotes overcoming of the division limit in human somatic cell.
Published In:
Bulletin of experimental biology and medicine, 137(5), 503-6 (2004)
Database ID:
RPEP-00933

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What was studied?

Epithalon Peptide Helps Human Cells Overcome the Hayflick Division Limit

What was found?

The tetrapeptide Epithalon (AEDG) enabled human pulmonary fibroblasts to exceed the Hayflick limit of cell divisions, extending replicative lifespan through telomerase activation — demonstrating anti-aging at the cellular replication level.

Read More on RethinkPeptides

Cite This Study

RPEP-00933·https://rethinkpeptides.com/research/RPEP-00933

APA

Khavinson, V Kh; Bondarev, I E; Butyugov, A A; Smirnova, T D. (2004). Peptide promotes overcoming of the division limit in human somatic cell.. Bulletin of experimental biology and medicine, 137(5), 503-6.

MLA

Khavinson, V Kh, et al. "Peptide promotes overcoming of the division limit in human somatic cell.." Bulletin of experimental biology and medicine, 2004.

RethinkPeptides

RethinkPeptides Research Database. "Peptide promotes overcoming of the division limit in human s..." RPEP-00933. Retrieved from https://rethinkpeptides.com/research/khavinson-2004-peptide-promotes-overcoming-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.